Risk signal mining of adverse events of satralizumab treatment for neuromyelitis optica spectrum disorder: based on the US Food and Drug Administration Adverse Event Reporting System

Shi Huahui, Ji Chunmei

PDF(386 KB)
PDF(386 KB)
Adverse Drug Reactions Journal ›› 2025, Vol. 27 ›› Issue (1) : 25-29. DOI: 10.3760/cma.j.cn114015-20240531-00407

Risk signal mining of adverse events of satralizumab treatment for neuromyelitis optica spectrum disorder: based on the US Food and Drug Administration Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 27(1): 25-29 https://doi.org/10.3760/cma.j.cn114015-20240531-00407

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(386 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉